Effects of losartan, in monotherapy or in association with hydrochlorothiazide, in chronic nephropathy resulting from losartan treatment during lactation

American Journal of Physiology - Renal Physiology

Volumn 301, Issue 3, 2011, Pages

  Fanelli, C ^a   Fernandes, B H V ^a   Machado, F G ^a   Okabe, C ^a   Malheiros, D M A C ^a   Fujihara, C K ^a   Zatz, R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin ii; Chronic kidney disease; Thiazides

Indexed keywords

CREATININE; GELATINASE A; GELATINASE B; HYDROCHLOROTHIAZIDE; LOSARTAN;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG EFFECT; ENZYME ACTIVITY; FEMALE; GLOMERULOSCLEROSIS; HYPERTENSION; KIDNEY INJURY; LACTATION; MALE; MICTURITION; MONOTHERAPY; MYOFIBROBLAST; NEPHRITIS; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; RENAL PROTECTION;

EID: 80052404815     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00042.2011     Document Type: Article

References (28)

1. Abbate M, Zoja C, Remuzzi G. How does proteinuria cause progressive renal damage? J Am Soc Nephrol 17: 2974-2984, 2006.
2. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 15: 290-301, 2000.
3. Fine LG, Norman JT. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney Int 74: 867-872, 2008.
4. Fujihara CK, Malheiros DM, Zatz R. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. Am J Physiol Renal Physiol 292: F1810-F1818, 2007.
5. Garcia-Estan J, Ortiz MC, O'Valle F, Alcaraz A, Navarro EG, Vargas F, Evangelista S, Atucha NM. Effects of angiotensin-converting-enzyme inhibitors in combination with diuretics on blood pressure and renal injury in nitric oxide-deficiency-induced hypertension in rats. Clin Sci (Lond) 110: 227-233, 2006.
6. Gonzalez-Villalobos R, Klassen RB, Allen PL, Navar LG, Hammond TG. Megalin binds and internalizes angiotensin II. Am J Physiol Renal Physiol 288: F420-F427, 2005.
7. Guron G, Adams MA, Sundelin B, Friberg P. Neonatal angiotensinconverting enzyme inhibition in the rat induces persistent abnormalities in renal function and histology. Hypertension 29: 91-97, 1997.
8. Haas CS, Gleason B, Lin S, Tramonti G, Kanwar YS. Matrix metalloproteinases in renal development. Connect Tissue Res 45: 73-85, 2004.
9. Heyman SN, Khamaisi M, Rosen S, Rosenberger C. Renal parenchymal hypoxia, hypoxia response and the progression of chronic kidney disease. Am J Nephrol 28: 998-1006, 2008.
10. Jepsen FL, Mortensen PB. Interstitial fibrosis of the renal cortex in minimal change lesion and its correlation with renal function. A quantitative study. Virchows Arch A Pathol Anat Histol 383: 265-270, 1979.
11. Kang DH, Hughes J, Mazzali M, Schreiner GF, Johnson RJ. Impaired angiogenesis in the remnant kidney model. II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12: 1448-1457, 2001.
12. Kleiner DE, Stetler-Stevenson WG. Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem 218: 325-329, 1994.
13. Kliem V, Johnson RJ, Alpers CE, Yoshimura A, Couser WG, Koch KM, Floege J. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats. Kidney Int 49: 666-678, 1996.
14. Kriz W, Hosser H, Hahnel B, Gretz N, Provoost AP. From segmental glomerulosclerosis to total nephron degeneration and interstitial fibrosis: a histopathological study in rat models and human glomerulopathies. Nephrol Dial Transplant 13: 2781-2798, 1998.
15. Lasaitiene D, Friberg P, Sundelin B, Chen Y. Neonatal RAS inhibition changes the phenotype of the developing thick ascending limb of Henle. Am J Physiol Renal Physiol 286: F1144-F1153, 2004.
16. Machado FG, Poppi EP, Fanelli C, Malheiros DM, Zatz R, Fujihara CK. AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury. Am J Physiol Renal Physiol 294: F1345-F1353, 2008.
17. Mancini G, Carbonara AO, Heremans JF. Immunochemical quantitation of antigens by single radial immunodiffusion. Immunochemistry 2: 235-254, 1965.
18. Miyazaki Y, Tsuchida S, Nishimura H, Pope JC, Harris RC, McKanna JM, Inagami T, Hogan BL, Fogo A, Ichikawa I. Angiotensin induces the urinary peristaltic machinery during the perinatal period. J Clin Invest 102: 1489-1497, 1998.
19. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25, 2006.
20. Noronha IL, Fujihara CK, Zatz R. The inflammatory component in progressive renal disease-are interventions possible? Nephrol Dial Transplant 17: 363-368, 2002.
21. Oroszlan M, Bieri M, Ligeti N, Farkas A, Meier B, Marti HP, Mohacsi P. Sirolimus and everolimus reduce albumin endocytosis in proximal tubule cells via an angiotensin II-dependent pathway. Transpl Immunol 23: 125-132, 2010.
22. Pohl M, Kaminski H, Castrop H, Bader M, Himmerkus N, Bleich M, Bachmann S, Theilig F. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285: 41935-41946, 2010.
23. Rodriguez-Iturbe B, Garcia GG. The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron Clin Pract 116: c81-c88, 2010.
24. Tanaka T, Nangaku M. The role of hypoxia, increased oxygen consumption, and hypoxia-inducible factor-1 alpha in progression of chronic kidney disease. Curr Opin Nephrol Hypertens 19: 43-50, 2010.
25. Tufro-McReddie A, Romano LM, Harris JM, Ferder L, Gomez RA. Angiotensin II regulates nephrogenesis and renal vascular development. Am J Physiol Renal Fluid Electrolyte Physiol 269: F110-F115, 1995.
26. Vogt L, Waanders F, Boomsma F, de Zeeuw D, Navis G. Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan. J Am Soc Nephrol 19: 999-1007, 2008.
27. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 47: 1-9, 1980.
28. Wu LL, Yang N, Roe CJ, Cooper ME, Gilbert RE, Atkins RC, Lan HY. Macrophage and myofibroblast proliferation in remnant kidney: role of angiotensin II. Kidney Int Suppl 63: S221-S225, 1997.